By Nilus Mattive On November 21, 202510:12 AM Eastern
Add this second pharma giant on this busy expiration Friday.
By Michael A. Robinson On November 21, 202507:00 AM Eastern
Here’s an interview I recently did to explain why I’m back ‘all-in’ on Apple.
By Juan M. Villaverde On November 20, 202505:20 PM Eastern
Plus, here’s when this downturn will likely bottom …
By Jurica Dujmovic On November 20, 202504:05 PM Eastern
The sector’s 40% YTD growth is nothing compared to its potential if traditional gamers give their blessing.
Supercycle Investor
Subscription
By Sean Brodrick On November 20, 202510:15 AM Eastern
And that’s just one force moving the markets.
By Chris Graebe On November 20, 202507:00 AM Eastern
Plus, here’s my checklist for analyzing what to do when a company IPOs.
By Marija Matic On November 19, 202505:30 PM Eastern
Here’s why it’s worth the wait if you missed this first chance to hop in.
By Mark Gough On November 19, 202504:17 PM Eastern
With the Senate’s draft of the Clarity Act finally released, the U.S. could get regulatory clarity by 2026.
By Chris Graebe On November 19, 202501:15 PM Eastern
But this beverage maker doesn’t quite satisfy for our Alliance.
By Sean Brodrick On November 19, 202511:27 AM Eastern
Don’t Let Market Jitters Get You Down